Timber Hill’s Regeneron Pharmaceuticals REGN Stock Holding History

Timber Hill’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,400	Closed	-$902K	–	534
2017 Q4	$902K	Sell	2,400 -1,600	-40%	-$648K	0.06%	299
2017 Q3	$1.79M	Sell	4,000 -3,800	-49%	-$1.81M	0.17%	107
2017 Q2	$3.83M	Sell	7,800 -18,300	-70%	-$8.01M	0.14%	105
2017 Q1	$10.1M	Sell	26,100 -24,100	-48%	-$8.93M	0.07%	195
2016 Q4	$18.4M	Sell	50,200 -700	-1%	-$266K	0.08%	186
2016 Q3	$20.5M	Sell	50,900 -8,100	-14%	-$3.25M	0.1%	172
2016 Q2	$20.6M	Sell	59,000 -2,000	-3%	-$770K	0.1%	176
2016 Q1	$22M	Buy	61,000 +23,800	+64%	+$9.81M	0.11%	160
2015 Q4	$20.2M	Sell	37,200 -68,800	-65%	-$37.3M	0.1%	154
2015 Q3	$49.3M	Buy	106,000 +76,200	+256%	+$40.9M	0.2%	83
2015 Q2	$15.2M	Sell	29,800 -1,200	-4%	-$586K	0.07%	250
2015 Q1	$14M	Sell	31,000 -13,600	-30%	-$5.76M	0.06%	255
2014 Q4	$18.3M	Buy	44,600 +7,400	+20%	+$2.91M	0.07%	219
2014 Q3	$13.4M	Sell	37,200 -12,800	-26%	-$4.29M	0.06%	275
2014 Q2	$14.1M	Sell	50,000 -5,700	-10%	-$1.69M	0.06%	247
2014 Q1	$16.7M	Sell	55,700 -3,200	-5%	-$986K	0.07%	222
2013 Q4	$16.2M	Buy	58,900 +5,500	+10%	+$1.58M	0.06%	267
2013 Q3	$16.7M	Buy	53,400 +11,600	+28%	+$3.05M	0.06%	265
2013 Q2	$9.4M	Buy	+41,800	New	+$9.73M	0.03%	472

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Timber Hill's REGN Position: Q2 2018 in Review

Timber Hill sold out of Regeneron Pharmaceuticals (REGN) in Q2 2018, closing a stake of 1,892 shares — an estimated $652K sold.

Timber Hill first reported a position in REGN in Q3 2013 and held it in 7 quarters. The position peaked at $4.01M in Q3 2015. 624 funds tracked by Wall St. Rank hold REGN as of Q2 2018.

Timber Hill reported no remaining Regeneron Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
Timber Hill sold 1,892 Regeneron Pharmaceuticals shares in Q2 2018, an estimated $652K.
Timber Hill first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 7 quarters.
Timber Hill's Regeneron Pharmaceuticals position peaked at $4.01M in Q3 2015.
624 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.